Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
[Diet and coronary disease].

Duodecim; laaketieteellinen aikakauskirja

Reunanen A.
PMID: 6764196
Duodecim. 1982;98(22):1748-60.

No abstract available.

Cite
Reunanen A. Ravinto ja sepelvaltimotauti. [Diet and coronary disease]. Duodecim. 1982;98(22):1748-60
Reunanen, A. (1982). Ravinto ja sepelvaltimotauti. [Diet and coronary disease]. Duodecim; laaketieteellinen aikakauskirja, 98(22), 1748-60.
Reunanen, A. "Ravinto ja sepelvaltimotauti." [Diet and coronary disease]. Duodecim; laaketieteellinen aikakauskirja vol. 98,22 (1982): 1748-60.
Reunanen A. Ravinto ja sepelvaltimotauti. [Diet and coronary disease]. Duodecim. 1982;98(22):1748-60. Finnish. PMID: 6764196.
Copy Download .nbib Format: NLM
Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients.

International journal for equity in health

Manderbacka K, Keskimäki I, Reunanen A, Klaukka T.
PMID: 18590524
Int J Equity Health. 2008 Jun 30;7:16. doi: 10.1186/1475-9276-7-16.

BACKGROUND: Earlier studies have mainly reported the use of antithrombotic drugs, beta-blockers and statins among hospital patient populations or MI patients. This study aimed to describe the use of these drugs among middle-aged Finnish coronary patients and to identify...

Cite
Manderbacka K, Keskimäki I, Reunanen A, et al. Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients. Int J Equity Health. 2008;7:16doi: 10.1186/1475-9276-7-16.
Manderbacka, K., Keskimäki, I., Reunanen, A., & Klaukka, T. (2008). Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients. International journal for equity in health, 716. https://doi.org/10.1186/1475-9276-7-16
Manderbacka, Kristiina, et al. "Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients." International journal for equity in health vol. 7 (2008): 16. doi: https://doi.org/10.1186/1475-9276-7-16
Manderbacka K, Keskimäki I, Reunanen A, Klaukka T. Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients. Int J Equity Health. 2008 Jun 30;7:16. doi: 10.1186/1475-9276-7-16. PMID: 18590524; PMCID: PMC2459171.
Copy Download .nbib Format: NLM
Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle.

Nutrition & metabolism

Rinnankoski-Tuikka R, Silvennoinen M, Torvinen S, Hulmi JJ, Lehti M, Kivelä R, Reunanen H, Kainulainen H.
PMID: 22682013
Nutr Metab (Lond). 2012 Jun 09;9(1):53. doi: 10.1186/1743-7075-9-53.

BACKGROUND: The expression of PDK4 is elevated by diabetes, fasting and other conditions associated with the switch from the utilization of glucose to fatty acids as an energy source. It is previously shown that peroxisome proliferator-activated receptor γ coactivator...

Cite
Rinnankoski-Tuikka R, Silvennoinen M, Torvinen S, et al. Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle. Nutr Metab (Lond). 2012;9(1):53doi: 10.1186/1743-7075-9-53.
Rinnankoski-Tuikka, R., Silvennoinen, M., Torvinen, S., Hulmi, J. J., Lehti, M., Kivelä, R., Reunanen, H., & Kainulainen, H. (2012). Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle. Nutrition & metabolism, 9(1), 53. https://doi.org/10.1186/1743-7075-9-53
Rinnankoski-Tuikka, Rita, et al. "Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle." Nutrition & metabolism vol. 9,1 (2012): 53. doi: https://doi.org/10.1186/1743-7075-9-53
Rinnankoski-Tuikka R, Silvennoinen M, Torvinen S, Hulmi JJ, Lehti M, Kivelä R, Reunanen H, Kainulainen H. Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle. Nutr Metab (Lond). 2012 Jun 09;9(1):53. doi: 10.1186/1743-7075-9-53. PMID: 22682013; PMCID: PMC3407034.
Copy Download .nbib Format: NLM
[Not Available].

Duodecim; laaketieteellinen aikakauskirja

Ala-Houhala M, Lahdes-Vasama T, Taskinen S, Fagerholm R, Rönnholm K, Reunanen M, Airikoski P.
PMID: 18020271
Duodecim. 2007;123(15):1881-2; author reply 1882-4.

No abstract available.

Cite
Ala-Houhala M, Lahdes-Vasama T, Taskinen S, et al. Vesikoureteraalisen refluksin merkitys lasten virtsatieinfektiossa. [Not Available]. Duodecim. 2007;123(15):1881-2; author reply 1882-4
Ala-Houhala, M., Lahdes-Vasama, T., Taskinen, S., Fagerholm, R., Rönnholm, K., Reunanen, M., & Airikoski, P. (2007). Vesikoureteraalisen refluksin merkitys lasten virtsatieinfektiossa. [Not Available]. Duodecim; laaketieteellinen aikakauskirja, 123(15), 1881-2; author reply 1882-4.
Ala-Houhala, Marja, et al. "Vesikoureteraalisen refluksin merkitys lasten virtsatieinfektiossa." [Not Available]. Duodecim; laaketieteellinen aikakauskirja vol. 123,15 (2007): 1881-2; author reply 1882-4.
Ala-Houhala M, Lahdes-Vasama T, Taskinen S, Fagerholm R, Rönnholm K, Reunanen M, Airikoski P. Vesikoureteraalisen refluksin merkitys lasten virtsatieinfektiossa. [Not Available]. Duodecim. 2007;123(15):1881-2; author reply 1882-4. Finnish. PMID: 18020271.
Copy Download .nbib Format: NLM
Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands.

Journal of drug delivery

Penate Medina O, Haikola M, Tahtinen M, Simpura I, Kaukinen S, Valtanen H, Zhu Y, Kuosmanen S, Cao W, Reunanen J, Nurminen T, Saris PE, Smith-Jones P, Bradbury M, Larson S, Kairemo K.
PMID: 21490745
J Drug Deliv. 2011;2011:160515. doi: 10.1155/2011/160515. Epub 2010 Dec 29.

Nanotechnology offers an alternative to conventional treatment options by enabling different drug delivery and controlled-release delivery strategies. Liposomes being especially biodegradable and in most cases essentially nontoxic offer a versatile platform for several different delivery approaches that can potentially...

Cite
Penate Medina O, Haikola M, Tahtinen M, et al. Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands. J Drug Deliv. 2010;2011:160515doi: 10.1155/2011/160515.
Penate Medina, O., Haikola, M., Tahtinen, M., Simpura, I., Kaukinen, S., Valtanen, H., Zhu, Y., Kuosmanen, S., Cao, W., Reunanen, J., Nurminen, T., Saris, P. E., Smith-Jones, P., Bradbury, M., Larson, S., & Kairemo, K. (2011). Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands. Journal of drug delivery, 2011160515. https://doi.org/10.1155/2011/160515
Penate Medina, Oula, et al. "Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands." Journal of drug delivery vol. 2011 (2011): 160515. doi: https://doi.org/10.1155/2011/160515
Penate Medina O, Haikola M, Tahtinen M, Simpura I, Kaukinen S, Valtanen H, Zhu Y, Kuosmanen S, Cao W, Reunanen J, Nurminen T, Saris PE, Smith-Jones P, Bradbury M, Larson S, Kairemo K. Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands. J Drug Deliv. 2011;2011:160515. doi: 10.1155/2011/160515. Epub 2010 Dec 29. PMID: 21490745; PMCID: PMC3066593.
Copy Download .nbib Format: NLM
Genetic variants associated with non-typhoidal Salmonella bacteraemia in African children.

Lancet (London, England)

Gilchrist JJ, Mills TC, Naranbhai V, Chapman SJ, Fairfax BP, Knight JC, Williams TN, Scott JA, MacLennan CA, Rautanen A, Hill AV.
PMID: 26312835
Lancet. 2015 Feb 26;385:S13. doi: 10.1016/S0140-6736(15)60328-2.

BACKGROUND: Non-typhoidal Salmonella (NTS) causes invasive and frequently fatal disease in African children. Existing strategies to prevent, diagnose, and treat NTS disease are inadequate. An improved understanding of the biology of invasive Salmonella infection will facilitate the development of...

Cite
Gilchrist JJ, Mills TC, Naranbhai V, et al. Genetic variants associated with non-typhoidal Salmonella bacteraemia in African children. Lancet. 2015;385:S13doi: 10.1016/S0140-6736(15)60328-2.
Gilchrist, J. J., Mills, T. C., Naranbhai, V., Chapman, S. J., Fairfax, B. P., Knight, J. C., Williams, T. N., Scott, J. A., MacLennan, C. A., Rautanen, A., Hill, A. V. (2015). Genetic variants associated with non-typhoidal Salmonella bacteraemia in African children. Lancet (London, England), 385S13. https://doi.org/10.1016/S0140-6736(15)60328-2
Gilchrist, James J, et al. "Genetic variants associated with non-typhoidal Salmonella bacteraemia in African children." Lancet (London, England) vol. 385 (2015): S13. doi: https://doi.org/10.1016/S0140-6736(15)60328-2
Gilchrist JJ, Mills TC, Naranbhai V, Chapman SJ, Fairfax BP, Knight JC, Williams TN, Scott JA, MacLennan CA, Rautanen A, Hill AV. Genetic variants associated with non-typhoidal Salmonella bacteraemia in African children. Lancet. 2015 Feb 26;385:S13. doi: 10.1016/S0140-6736(15)60328-2. PMID: 26312835; PMCID: PMC6858854.
Copy Download .nbib Format: NLM
Furfural and 5-Hydroxymethylfurfural Production from Sugar Mixture Using Deep Eutectic Solvent/MIBK System.

ChemistryOpen

Rusanen A, Lappalainen K, Kärkkäinen J, Lassi U.
PMID: 34617679
ChemistryOpen. 2021 Oct;10(10):1004-1012. doi: 10.1002/open.202100163.

Choline chloride (ChCl) / glycolic acid (GA) deep eutectic solvent (DES) media with high water content but without any additional catalyst are introduced in furfural and 5-hydroxymethylfurfural (HMF) production. The effects of water content, reaction time, and reaction temperature...

Cite
Rusanen A, Lappalainen K, Kärkkäinen J, et al. Furfural and 5-Hydroxymethylfurfural Production from Sugar Mixture Using Deep Eutectic Solvent/MIBK System. ChemistryOpen. 2021;10(10):1004-1012doi: 10.1002/open.202100163.
Rusanen, A., Lappalainen, K., Kärkkäinen, J., & Lassi, U. (2021). Furfural and 5-Hydroxymethylfurfural Production from Sugar Mixture Using Deep Eutectic Solvent/MIBK System. ChemistryOpen, 10(10), 1004-1012. https://doi.org/10.1002/open.202100163
Rusanen, Annu, et al. "Furfural and 5-Hydroxymethylfurfural Production from Sugar Mixture Using Deep Eutectic Solvent/MIBK System." ChemistryOpen vol. 10,10 (2021): 1004-1012. doi: https://doi.org/10.1002/open.202100163
Rusanen A, Lappalainen K, Kärkkäinen J, Lassi U. Furfural and 5-Hydroxymethylfurfural Production from Sugar Mixture Using Deep Eutectic Solvent/MIBK System. ChemistryOpen. 2021 Oct;10(10):1004-1012. doi: 10.1002/open.202100163. PMID: 34617679; PMCID: PMC8495682.
Copy Download .nbib Format: NLM
Is reducing new particle formation a plausible solution to mitigate particulate air pollution in Beijing and other Chinese megacities?.

Faraday discussions

Kulmala M, Dada L, Daellenbach KR, Yan C, Stolzenburg D, Kontkanen J, Ezhova E, Hakala S, Tuovinen S, Kokkonen TV, Kurppa M, Cai R, Zhou Y, Yin R, Baalbaki R, Chan T, Chu B, Deng C, Fu Y, Ge M, He H, Heikkinen L, Junninen H, Liu Y, Lu Y, Nie W, Rusanen A, Vakkari V, Wang Y, Yang G, Yao L, Zheng J, Kujansuu J, Kangasluoma J, Petäjä T, Paasonen P, Järvi L, Worsnop D, Ding A, Liu Y, Wang L, Jiang J, Bianchi F, Kerminen VM.
PMID: 33290451
Faraday Discuss. 2021 Mar 01;226:334-347. doi: 10.1039/d0fd00078g. Epub 2020 Dec 08.

Atmospheric gas-to-particle conversion is a crucial or even dominant contributor to haze formation in Chinese megacities in terms of aerosol number, surface area and mass. Based on our comprehensive observations in Beijing during 15 January 2018-31 March 2019, we...

Cite
Kulmala M, Dada L, Daellenbach KR, et al. Is reducing new particle formation a plausible solution to mitigate particulate air pollution in Beijing and other Chinese megacities?. Faraday Discuss. 2020;226:334-347doi: 10.1039/d0fd00078g.
Kulmala, M., Dada, L., Daellenbach, K. R., Yan, C., Stolzenburg, D., Kontkanen, J., Ezhova, E., Hakala, S., Tuovinen, S., Kokkonen, T. V., Kurppa, M., Cai, R., Zhou, Y., Yin, R., Baalbaki, R., Chan, T., Chu, B., Deng, C., Fu, Y., Ge, M., He, H., Heikkinen, L., Junninen, H., Liu, Y., Lu, Y., Nie, W., Rusanen, A., Vakkari, V., Wang, Y., Yang, G., Yao, L., Zheng, J., Kujansuu, J., Kangasluoma, J., Petäjä, T., Paasonen, P., Järvi, L., Worsnop, D., Ding, A., Liu, Y., Wang, L., Jiang, J., Bianchi, F., & Kerminen, V. M. (2021). Is reducing new particle formation a plausible solution to mitigate particulate air pollution in Beijing and other Chinese megacities?. Faraday discussions, 226334-347. https://doi.org/10.1039/d0fd00078g
Kulmala, Markku, et al. "Is reducing new particle formation a plausible solution to mitigate particulate air pollution in Beijing and other Chinese megacities?." Faraday discussions vol. 226 (2021): 334-347. doi: https://doi.org/10.1039/d0fd00078g
Kulmala M, Dada L, Daellenbach KR, Yan C, Stolzenburg D, Kontkanen J, Ezhova E, Hakala S, Tuovinen S, Kokkonen TV, Kurppa M, Cai R, Zhou Y, Yin R, Baalbaki R, Chan T, Chu B, Deng C, Fu Y, Ge M, He H, Heikkinen L, Junninen H, Liu Y, Lu Y, Nie W, Rusanen A, Vakkari V, Wang Y, Yang G, Yao L, Zheng J, Kujansuu J, Kangasluoma J, Petäjä T, Paasonen P, Järvi L, Worsnop D, Ding A, Liu Y, Wang L, Jiang J, Bianchi F, Kerminen VM. Is reducing new particle formation a plausible solution to mitigate particulate air pollution in Beijing and other Chinese megacities?. Faraday Discuss. 2021 Mar 01;226:334-347. doi: 10.1039/d0fd00078g. Epub 2020 Dec 08. PMID: 33290451.
Copy Download .nbib Format: NLM
The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

Thome J, Deloyer J, Coogan AN, Bailey-Rodriguez D, da Cruz E Silva OAB, Faltraco F, Grima C, Gudjonsson SO, Hanon C, Hollý M, Joosten J, Karlsson I, Kelemen G, Korman M, Krysta K, Lichterman B, Loganovsky K, Marazziti D, Maraitou M, Mertens deWilmars S, Reunamen M, Rexhaj S, Sancaktar M, Sempere J, Tournier I, Weynant E, Vis C, Lebas MC, Fond-Harmant L.
PMID: 33143529
World J Biol Psychiatry. 2021 Sep;22(7):516-525. doi: 10.1080/15622975.2020.1844290. Epub 2020 Dec 23.

PURPOSE: The current COVID-19 pandemic confronts psychiatric patients and mental health services with unique and severe challenges.METHODS: In order to identify these trans-national challenges across Europe, an RESULTS: A number of important themes and issues were raised for the...

Cite
Thome J, Deloyer J, Coogan AN, et al. The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe. World J Biol Psychiatry. 2020;22(7):516-525doi: 10.1080/15622975.2020.1844290.
Thome, J., Deloyer, J., Coogan, A. N., Bailey-Rodriguez, D., da Cruz E Silva, O. A. B., Faltraco, F., Grima, C., Gudjonsson, S. O., Hanon, C., Hollý, M., Joosten, J., Karlsson, I., Kelemen, G., Korman, M., Krysta, K., Lichterman, B., Loganovsky, K., Marazziti, D., Maraitou, M., Mertens deWilmars, S., Reunamen, M., Rexhaj, S., Sancaktar, M., Sempere, J., Tournier, I., Weynant, E., Vis, C., Lebas, M. C., & Fond-Harmant, L. (2021). The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 22(7), 516-525. https://doi.org/10.1080/15622975.2020.1844290
Thome, Johannes, et al. "The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe." The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry vol. 22,7 (2021): 516-525. doi: https://doi.org/10.1080/15622975.2020.1844290
Thome J, Deloyer J, Coogan AN, Bailey-Rodriguez D, da Cruz E Silva OAB, Faltraco F, Grima C, Gudjonsson SO, Hanon C, Hollý M, Joosten J, Karlsson I, Kelemen G, Korman M, Krysta K, Lichterman B, Loganovsky K, Marazziti D, Maraitou M, Mertens deWilmars S, Reunamen M, Rexhaj S, Sancaktar M, Sempere J, Tournier I, Weynant E, Vis C, Lebas MC, Fond-Harmant L. The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe. World J Biol Psychiatry. 2021 Sep;22(7):516-525. doi: 10.1080/15622975.2020.1844290. Epub 2020 Dec 23. PMID: 33143529.
Copy Download .nbib Format: NLM
Characterization of Highly Mucus-Adherent Non-GMO Derivatives of .

Frontiers in bioengineering and biotechnology

Rasinkangas P, Tytgat HLP, Ritari J, Reunanen J, Salminen S, Palva A, Douillard FP, de Vos WM.
PMID: 32974330
Front Bioeng Biotechnol. 2020 Aug 19;8:1024. doi: 10.3389/fbioe.2020.01024. eCollection 2020.

No abstract available.

Cite
Rasinkangas P, Tytgat HLP, Ritari J, et al. Characterization of Highly Mucus-Adherent Non-GMO Derivatives of . Front Bioeng Biotechnol. 2020;8:1024doi: 10.3389/fbioe.2020.01024.
Rasinkangas, P., Tytgat, H. L. P., Ritari, J., Reunanen, J., Salminen, S., Palva, A., Douillard, F. P., & de Vos, W. M. (2020). Characterization of Highly Mucus-Adherent Non-GMO Derivatives of . Frontiers in bioengineering and biotechnology, 81024. https://doi.org/10.3389/fbioe.2020.01024
Rasinkangas, Pia, et al. "Characterization of Highly Mucus-Adherent Non-GMO Derivatives of ." Frontiers in bioengineering and biotechnology vol. 8 (2020): 1024. doi: https://doi.org/10.3389/fbioe.2020.01024
Rasinkangas P, Tytgat HLP, Ritari J, Reunanen J, Salminen S, Palva A, Douillard FP, de Vos WM. Characterization of Highly Mucus-Adherent Non-GMO Derivatives of . Front Bioeng Biotechnol. 2020 Aug 19;8:1024. doi: 10.3389/fbioe.2020.01024. eCollection 2020. PMID: 32974330; PMCID: PMC7466733.
Copy Download .nbib Format: NLM
Presence of distinctive microbiome in the first-pass meconium of newborn infants.

Scientific reports

Turunen J, Tejesvi MV, Paalanne N, Hekkala J, Lindgren O, Kaakinen M, Pokka T, Kaisanlahti A, Reunanen J, Tapiainen T.
PMID: 34593932
Sci Rep. 2021 Sep 30;11(1):19449. doi: 10.1038/s41598-021-98951-4.

We critically evaluated the fetal microbiome concept in 44 neonates with placenta, amniotic fluid, and first-pass meconium samples. Placental histology showed no signs of inflammation. Meconium samples were more often bacterial culture positive after vaginal delivery. In next-generation sequencing...

Cite
Turunen J, Tejesvi MV, Paalanne N, et al. Presence of distinctive microbiome in the first-pass meconium of newborn infants. Sci Rep. 2021;11(1):19449doi: 10.1038/s41598-021-98951-4.
Turunen, J., Tejesvi, M. V., Paalanne, N., Hekkala, J., Lindgren, O., Kaakinen, M., Pokka, T., Kaisanlahti, A., Reunanen, J., & Tapiainen, T. (2021). Presence of distinctive microbiome in the first-pass meconium of newborn infants. Scientific reports, 11(1), 19449. https://doi.org/10.1038/s41598-021-98951-4
Turunen, Jenni, et al. "Presence of distinctive microbiome in the first-pass meconium of newborn infants." Scientific reports vol. 11,1 (2021): 19449. doi: https://doi.org/10.1038/s41598-021-98951-4
Turunen J, Tejesvi MV, Paalanne N, Hekkala J, Lindgren O, Kaakinen M, Pokka T, Kaisanlahti A, Reunanen J, Tapiainen T. Presence of distinctive microbiome in the first-pass meconium of newborn infants. Sci Rep. 2021 Sep 30;11(1):19449. doi: 10.1038/s41598-021-98951-4. PMID: 34593932; PMCID: PMC8484610.
Copy Download .nbib Format: NLM
Fatty liver score and 15-year incidence of type 2 diabetes.

Hepatology international

Kotronen A, Laaksonen MA, Heliövaara M, Reunanen A, Tuomilehto J, Yki-Järvinen H, Peltonen M, Knekt P.
PMID: 26201794
Hepatol Int. 2013 Jun;7(2):610-21. doi: 10.1007/s12072-013-9430-7. Epub 2013 Mar 12.

PURPOSE: Both non-alcoholic fatty liver (NAFL) and alcoholic fatty liver (AFL) are strongly associated with obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM). Recently, also the vitamin D level has been associated with these and may also be...

Cite
Kotronen A, Laaksonen MA, Heliövaara M, et al. Fatty liver score and 15-year incidence of type 2 diabetes. Hepatol Int. 2013;7(2):610-21doi: 10.1007/s12072-013-9430-7.
Kotronen, A., Laaksonen, M. A., Heliövaara, M., Reunanen, A., Tuomilehto, J., Yki-Järvinen, H., Peltonen, M., & Knekt, P. (2013). Fatty liver score and 15-year incidence of type 2 diabetes. Hepatology international, 7(2), 610-21. https://doi.org/10.1007/s12072-013-9430-7
Kotronen, Anna, et al. "Fatty liver score and 15-year incidence of type 2 diabetes." Hepatology international vol. 7,2 (2013): 610-21. doi: https://doi.org/10.1007/s12072-013-9430-7
Kotronen A, Laaksonen MA, Heliövaara M, Reunanen A, Tuomilehto J, Yki-Järvinen H, Peltonen M, Knekt P. Fatty liver score and 15-year incidence of type 2 diabetes. Hepatol Int. 2013 Jun;7(2):610-21. doi: 10.1007/s12072-013-9430-7. Epub 2013 Mar 12. PMID: 26201794.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries